UFP Stock (NASDAQ:UFPT)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$232.48

52W Range

$173.86 - $274.93

50D Avg

$210.98

200D Avg

$217.28

Market Cap

$1.85B

Avg Vol (3M)

$210.46K

Beta

1.10

Div Yield

-

UFPT Company Profile


UFP Technologies, Inc. specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams, films, and plastics. A significant portion of its business is dedicated to the medical sector, where its single-use and single-patient devices and parts are integral to a broad spectrum of applications, including general medical devices, disposable wound care, infection control, minimally invasive surgical tools, wearable technologies, orthopedic soft goods, and protective packaging for orthopedic implants. Beyond healthcare, the company extends its expertise to the automotive, aerospace and defense, consumer, electronics, and industrial markets. Here, its engineered products and components are incorporated into diverse items such as military uniform and gear, automotive interior trim, athletic padding, sustainable protective packaging, air filtration systems, abrasive nail files, and custom protective cases and inserts. UFP Technologies markets and distributes its offerings across the United States, predominantly through a direct sales force supported by independent manufacturer representatives. The company, established in 1963, is headquartered in Newburyport, Massachusetts.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4,146

IPO Date

Dec 17, 1993

Website

UFPT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25
Tooling And Machinery$4.50M
Engineering And Development$6.94M
Product$591.36M

Fiscal year ends in Dec 25 | Currency in USD

UFPT Financial Summary


Dec 25Dec 24Dec 23
Revenue$602.80M$504.42M$400.07M
Operating Income$92.34M$80.90M$57.66M
Net Income$68.31M$58.98M$44.92M
EBITDA$115.74M$95.80M$68.95M
Basic EPS$8.87$7.69$5.89
Diluted EPS$8.77$7.58$5.83

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 05, 26 | 8:30 AM
Q4 25Feb 25, 26 | 12:00 AM
Q3 25Nov 04, 25 | 8:30 AM

Peer Comparison


TickerCompany
OMCLOmnicell, Inc.
SSIISS Innovations International, Inc.
ESTAEstablishment Labs Holdings Inc.
SEMSelect Medical Holdings Corporation
SDGRSchrödinger, Inc.
PGNYProgyny, Inc.
CNMDCONMED Corporation
AHCOAdaptHealth Corp.
ALVOAlvotech
IMNMImmunome, Inc.